These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 28254487

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis and structure-activity relationships of novel warfarin derivatives.
    Gebauer M.
    Bioorg Med Chem; 2007 Mar 15; 15(6):2414-20. PubMed ID: 17275317
    [Abstract] [Full Text] [Related]

  • 3. The in vivo effects of oral anticoagulants in man: comparison between liver and non-hepatic tissues.
    de Boer-van den Berg M, Thijssen HH, Vermeer C.
    Thromb Haemost; 1988 Apr 08; 59(2):147-50. PubMed ID: 3260413
    [Abstract] [Full Text] [Related]

  • 4. Vitamin K antagonism of coumarin intoxication in the rat.
    Wallin R, Patrick SD, Ballard JO.
    Thromb Haemost; 1986 Apr 30; 55(2):235-9. PubMed ID: 2424118
    [Abstract] [Full Text] [Related]

  • 5. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
    Thijssen HH, Baars LG, Vervoort-Peters HT.
    Br J Pharmacol; 1988 Nov 30; 95(3):675-82. PubMed ID: 3207986
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF, Suttie JW.
    Biochemistry; 1982 May 11; 21(10):2406-11. PubMed ID: 6807339
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
    Danis O, Yuce-Dursun B, Gunduz C, Ogan A, Sener G, Bulut M, Yarat A.
    Arzneimittelforschung; 2010 May 11; 60(10):617-20. PubMed ID: 21125812
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
    Abdelhafez OM, Amin KM, Batran RZ, Maher TJ, Nada SA, Sethumadhavan S.
    Bioorg Med Chem; 2010 May 15; 18(10):3371-8. PubMed ID: 20435480
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent findings in understanding the biological function of vitamin K.
    Uotila L, Suttie JW.
    Med Biol; 1982 Feb 15; 60(1):16-24. PubMed ID: 6803084
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle.
    Chen X, Li C, Jin DY, Ingram B, Hao Z, Bai X, Stafford DW, Hu K, Tie JK.
    Blood; 2020 Aug 13; 136(7):898-908. PubMed ID: 32374827
    [Abstract] [Full Text] [Related]

  • 13. Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats.
    Grandemange A, Kohn MH, Lasseur R, Longin-Sauvageon C, Berny P, Benoit E.
    Pharmacogenet Genomics; 2009 Oct 13; 19(10):742-50. PubMed ID: 19752778
    [Abstract] [Full Text] [Related]

  • 14. A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit.
    Park BK, Leck JB.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3635-9. PubMed ID: 7181945
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and pharmacological investigations of some 4-hydroxycoumarin derivatives.
    Manolov I, Danchev ND.
    Arch Pharm (Weinheim); 2003 Apr 15; 336(2):83-94. PubMed ID: 12761761
    [Abstract] [Full Text] [Related]

  • 16. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
    Ge B, Zhang Z, Lam TT, Zuo Z.
    Biopharm Drug Dispos; 2017 Jan 15; 38(1):33-49. PubMed ID: 27925234
    [Abstract] [Full Text] [Related]

  • 17. Monitoring of antivitamin K-dependent anticoagulation in rodents - Towards an evolution of the methodology to detect resistance in rodents.
    Lefebvre S, Hascoët C, Damin-Pernik M, Rannou B, Benoit E, Lattard V.
    Pestic Biochem Physiol; 2017 May 15; 138():29-36. PubMed ID: 28456301
    [Abstract] [Full Text] [Related]

  • 18. A cellular system for quantitation of vitamin K cycle activity: structure-activity effects on vitamin K antagonism by warfarin metabolites.
    Haque JA, McDonald MG, Kulman JD, Rettie AE.
    Blood; 2014 Jan 23; 123(4):582-9. PubMed ID: 24297869
    [Abstract] [Full Text] [Related]

  • 19. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.
    Wallin R.
    Biochem J; 1986 Jun 15; 236(3):685-93. PubMed ID: 3098238
    [Abstract] [Full Text] [Related]

  • 20. Structural Modeling Insights into Human VKORC1 Phenotypes.
    Czogalla KJ, Watzka M, Oldenburg J.
    Nutrients; 2015 Aug 14; 7(8):6837-51. PubMed ID: 26287237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.